الانتقال الى المحتويات

طب الصدمات والطوارئ

إدارة مضاد التخثر وعكسه

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (يفتح نافذة جديدة)

Coccolini F, Shander A, Ceresoli M, Moore E, Tian B, Parini D, Sartelli M, Sakakushev B, Doklestich K, Abu-Zidan F, Horer T, Shelat V, Hardcastle T, Bignami E, Kirkpatrick A, Weber D, Kryvoruchko I, Leppaniemi A, Tan E, Kessel B, Isik A, Cremonini C, Forfori F, Ghiadoni L, Chiarugi M, Ball C, Ottolino P, Hecker A, Mariani D, Melai E, Malbrain M, Agostini V, Podda M, Picetti E, Kluger Y, Rizoli S, Litvin A, Maier R, Beka SG, De Simone B, Bala M, Perez AM, Ordonez C, Bodnaruk Z, Cui Y, Calatayud AP, de Angelis N, Amico F, Pikoulis E, Damaskos D, Coimbra R, Chirica M, Biffl WL, Catena F

Source‎: World J Emerg Surg 2024;19(1):26.

مفهرسة‎: PubMed 39010099

DOI‎: 10.1186/s13017-024-00554-7

https://pubmed.ncbi.nlm.nih.gov/39010099/ (يفتح نافذة جديدة)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (يفتح نافذة جديدة)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Source‎: Am J Hematol 2012;87 Suppl 1:S141-5.

مفهرسة‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (يفتح نافذة جديدة)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (يفتح نافذة جديدة)

Levi M, Eerenberg E, Kamphuisen PW.

Source‎: J Thromb Haemost 2011;9(9):1705-12.

مفهرسة‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (يفتح نافذة جديدة)

Emergency reversal of warfarin anticoagulation. (يفتح نافذة جديدة)

Lin Y, Callum J.

Source‎: CMAJ 2010;182(18):2004.

مفهرسة‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (يفتح نافذة جديدة)

Management of anticoagulation agents in trauma patients. (يفتح نافذة جديدة)

McCoy CC, Lawson JH, Shapiro ML.

Source‎: Clin Lab Med 2014;34(3):563-74.

مفهرسة‎: PubMed 25168942

DOI‎: 10.1016/j.cll.2014.06.013

https://www.ncbi.nlm.nih.gov/pubmed/25168942 (يفتح نافذة جديدة)

Idarucizumab for dabigatran reversal - full cohort analysis. (يفتح نافذة جديدة)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Source‎: N Engl J Med 2017;377(5):431-41.

مفهرسة‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (يفتح نافذة جديدة)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (يفتح نافذة جديدة)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Source‎: Anesth Analg 2011;113(4):703-10.

مفهرسة‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (يفتح نافذة جديدة)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (يفتح نافذة جديدة)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Source‎: World Neurosurg 2014;81(1):110-5.

مفهرسة‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (يفتح نافذة جديدة)